
    
      The study is a prospective, non-randomized, multi-center observational study designed to
      evaluate the utilization of diagnostic capabilities, indications, MRI scanning capabilities
      and clinical outcomes of patients implanted with SJM pacemakers.

      The total duration of the study is expected to be approximately 30 months. The clinical study
      will be conducted in up to 160 centers across Europe, Middle East, Africa, (EMEA region) and
      Asia, Australia and New Zealand (Asia-Pac region). Approximately 2016 subjects will be
      enrolled in this study. Subjects will be followed for 1 year after pacemaker implant.
    
  